These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37868546)

  • 1. Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II.
    Khludenev G; Le Cam E; Ainapurapu BB
    Cureus; 2023 Sep; 15(9):e45666. PubMed ID: 37868546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe ketoacidosis in a patient with spinal muscular atrophy.
    Lakkis B; El Chediak A; Hashash JG; Koubar SH
    CEN Case Rep; 2018 Nov; 7(2):292-295. PubMed ID: 29978296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.
    Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ
    Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe ketoacidosis induced by short-term starvation in a patient with spinal muscular atrophy].
    Inui R; Fujiwara S; Kawamoto M; Kohara N
    Rinsho Shinkeigaku; 2020 Apr; 60(4):268-271. PubMed ID: 32238745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic Ketoacidosis in Spinal Muscular Atrophy.
    Stoimenis D; Spyridonidou C; Theofanidou S; Petridis N; Papaioannou N; Iasonidou C; Kapravelos N
    Case Rep Pediatr; 2019; 2019():2862916. PubMed ID: 30809411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II: Further Evidence of Extraneural Pathology Due to Survival Motor Neuron 1 Mutation?
    Lamarca NH; Golden L; John RM; Naini A; Vivo DC; Sproule DM
    J Child Neurol; 2013 Nov; 28(11):1517-1520. PubMed ID: 23034979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy and Ependymoma.
    Albakr A; Abbas F; Al-Jehani H; Ammar A
    Saudi J Med Med Sci; 2017; 5(2):163-166. PubMed ID: 30787777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran.
    Shervin Badv R; Nilipour Y; Rahimi-Dehgolan S; Rashidi-Nezhad A; Ghahvechi Akbari M
    Int Med Case Rep J; 2019; 12():155-159. PubMed ID: 31213928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of type IV spinal muscular atrophy (SMA) with myoclonic epilepsy within a single family.
    Liyanage DS; Pathberiya LS; Gooneratne IK; Vithanage KK; Gamage R
    Int Arch Med; 2014; 7(1):42. PubMed ID: 25278999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early disruption of neurovascular units and microcirculatory dysfunction in the spinal cord in spinal muscular atrophy type I.
    Nobutoki T; Ihara T
    Med Hypotheses; 2015 Dec; 85(6):842-5. PubMed ID: 26433686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and limitations for the treatment of spinal muscular atrophy.
    Day JW; Howell K; Place A; Long K; Rossello J; Kertesz N; Nomikos G
    BMC Pediatr; 2022 Nov; 22(1):632. PubMed ID: 36329412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy.
    Iftikhar M; Frey J; Shohan MJ; Malek S; Mousa SA
    Pharmacol Ther; 2021 Apr; 220():107719. PubMed ID: 33130193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood spinal muscular atrophy.
    Younger DS; Mendell JR
    Handb Clin Neurol; 2023; 196():43-58. PubMed ID: 37620083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).
    Salort-Campana E; Quijano-Roy S
    Arch Pediatr; 2020 Dec; 27(7S):7S23-7S28. PubMed ID: 33357593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal muscular atrophy type 2 patient who survived 61 years: an autopsy case report.
    Yamadera M; Saito T; Shinohara M; Nishio H; Murayama S; Fujimura H
    Neuropathology; 2022 Apr; 42(2):141-146. PubMed ID: 35144320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.